Abstract
We previously reported that transferrin (Tf)-modified liposomes (Tf-L) additionally modified with a cholesterylated pH-sensitive fusogenic peptide (Chol-GALA) can release an encapsulated aqueous phase marker to cytosol via endosomal membrane fusion. However, further obstacles need to be overcome to bring the Tf-L to the level of a viral-like gene delivery system. In this study, we developed a novel packaging method to encapsulate condensed plasmid DNA into PEgylated Tf-L (Tf-PEG-L) to form a core–shell-type nanoparticle. The most difficult challenge was to provide a mechanism of escape for the condensed core from endosome to cytosol in the presence of polyethylene glycol (PEG). We hypothesized that a membrane-introduced Chol-GALA and a PEgylated GALA would interact synergistically to induce membrane fusion between liposome and endosome. By simultaneously incorporating Chol-GALA into the membrane of Tf-PEG-L and GALA at tips of PEG chains, a condensed core was released into cytosol, and transfection acitivty increased 100-fold. We concluded that topological control was responsible for the synergistic effect of GALA derivatives introduced on Tf-PEG-L.
Similar content being viewed by others
Abbreviations
- Chol:
-
Cholesterol
- Chol-GALA:
-
Cholesteryl-GALA
- CLSM:
-
Confocal laser scanning microscopy
- DCP:
-
Dicetylphosphate
- DOPE:
-
Dioleoyl phosphatidylethanolamine
- DPC:
-
DNA/polycation complex
- DSPE-PEG2000:
-
Distearyl phosphatidyl ethanolamine-polyethylenglycol 2000
- EPC:
-
Egg phosphatidylcholine
- FITC:
-
Fluorescein isothiocyanate
- HA:
-
Hemagglutinin
- MEND:
-
Multifunctional envelope-type nanodevice
- NBD-DOPE:
-
4-Nitrobenzo-2-oxa-1,3-diazolyl-DOPE
- N/P:
-
Nitrogen/phosphate
- OGP:
-
n-Octyl β-D-glucopyranoside
- pDNA:
-
Plasmid DNA
- PDP-PE:
-
N-[3-(2-pyridyldithio)propionate]-1,2-dipalmitoyl-sn-glycero-3-phosphatidylethanolamine
- PEG-GALA:
-
PEgylated GALA
- PLL:
-
Poly-L-lysine
- Rho-DOPE:
-
Lissamine rhodamine B-DOPE
- SPDP:
-
3-(2-Pyridyldithio)propionic acid N-hydroxysuccinimide ester
- S-Rh:
-
Sulforhodamine B
- SUV*:
-
Detergent-rich small unilamellar vesicle
- Tf:
-
Transferrin
- Tf-L:
-
Tf-modified liposomes
- Tf-PEG-L:
-
PEgylated Tf-L
- Tf-PEG-L(Chol-GALA):
-
Tf-PEG-L modified with Chol-GALA
- Tf-PEG-L(Chol&PEG-GALA):
-
Tf-PEG-L modified with Chol-GALA and PEG-GALA
- Tf-PEG-L(PEG-GALA):
-
Tf-PEG-L modified with PEG-GALA
References
Hughson FM (1995) Curr Biol 5:265–274
Nemerow GR (2000) Virology 274:1–4
Harel A, Forbes DJ (2001) Nature Cell Biol 3:E267–E269
Jooss K, Chirmule N (2003) Gene Ther 10:955–963
Meier O, Greber UF (2003) J Gene Med 5:451–462
Lakadamyali M, Rust MJ, Zhuang X (2004) Microbes Infect 6:929–936
Smith AE, Helenius A (2004) Science 304:237–242
Portela A, Digard P (2002) J General Virol 83:723–734
Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T, Maruyama K, Kamiya H, Harashima H (2004) Biochemistry 43:5618–5628
Simões S, Slepushkin V, Gaspar R, Pedroso de Lima MC, Düzgüneş N (1998) Gene Ther 5:955–964
Nir S, Nicol F, Szoka FC Jr (1999) Mol Membr Biol 16:95–101
Simões S, Slepushkin V, Pires P, Gaspar R, Pedroso de Lima MC, Düzgüneş N (1999) Gene Ther 6:1798–1807
Li W, Nicol F, Szoka FC Jr (2004) Adv Drug Deliv Rev 56:967–985
Sasaki K, Kogure K, Chaki S, Kihira Y, Ueno M, Harashima H (2005) Int J Pharm 296:142–150
Huang J, Ito Y, Kobune M, Sasaki K, Nakamura K, Dehari H, Takahashi K, Ikeda K, Uchida H, Kato K, Hamada H (2003) J Gene Med 5:900–908
Danev R, Nagayama K (2001) Ultramicroscopy 88:243–252
Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H (2004) Int J Pharm 281:25–33
Kamiya H, Fujimura Y, Matsuoka I, Harashima H (2002) Biochem Biophys Res Commun 298:591–597
Kogure K, Moriguchi R, Sasaki K, Ueno M, Futaki S, Harashima H (2004) J Control Release 98:317–323
Ueno M, Akechi Y (1991) Chem Lett 1991:1801–1804
Ohota A, Danev R, Nagayama K, Mita T, Asakawa T, Miyagishi S (2006) Langmuir 22:8472–8477
Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK (1995) Cancer Res 55:3752–3756
Masuda T, Akita H, Harashima H (2005) FEBS Lett 579:2143–2148
Sorgi FL, Bhattacharya S, Huang L (1997) Gene Ther 4:961–968
Khalil IA, Kogure K, Futaki S, Hama S, Akita H, Ueno M, Kishida H, Kudoh M, Mishina Y, Kataoka K, Yamada M, Harashima H (2007) Gene Ther 14:682–689
Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, Hope MJ, Scherrer P, Cullis PR (1999) Gene Ther 6:271–281
Steinman RM, Brodie SE, Cohn ZA (1976) J Cell Biol 68:665–687
Moriguchi R, Kogure K, Akita H, Futaki S, Miyagishi M, Taira K, Harashima H (2005) Int J Pharm 301:277–285
Acknowledgements
This work was supported, in part, by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Grants-in-Aid for Scientific Research on Priority Areas from the Japan Society for the Promotion of Science. The authors wish to thank Dr. Daryl Henderson for his helpful advice in writing the English manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Kentaro Sasaki and Kentaro Kogure contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 63.8 KB)
Rights and permissions
About this article
Cite this article
Sasaki, K., Kogure, K., Chaki, S. et al. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives. Anal Bioanal Chem 391, 2717–2727 (2008). https://doi.org/10.1007/s00216-008-2012-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-008-2012-1